ObsEva
Develops innovative drugs addressing PREgnancy issues
ObsEva has raised €80M across 2 funding rounds from 5 investors, most recently a Series B round in Nov 2015. Based in Plan-les-Ouates, Switzerland; founded 2012; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€80M
€80,061,287
Funding rounds
2
Investors
5
distinct backers
Active since
2013-08
latest 2015-11
Funding by year
EUR raised per yearObsEva — funding by year — interactive chart.
Data table
| ObsEva — funding by year | |
|---|---|
| 2013 | €26M |
| 2015 | €54M |
Signals
High confidenceRaise-next likelihood10
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood9
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2015-11-01 | Series B | €54M | HBM Partners,New Enterprise Associates,Novo Holdings,OrbiMed,Sofinnova Partners | View deal → |
| 2013-08-01 | Series A | €26M | Novo Holdings,Sofinnova Partners | View deal → |
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData